Table 4.
Several patients with a positive or negative result in the subtraction of post-treatment slopes from pretreatment slopes per treatment group.
| Post-treatment—Pretreatment MD Slope | Post-treatment—Pretreatment VFI Slope | |||||
|---|---|---|---|---|---|---|
| Positive (Number of Cases) |
Negative (Number of Cases) |
p Value |
Positive (Number of Cases) |
Negative (Number of Cases) |
p Value |
|
| Global | 40 | 26 | 0.085 | 39 | 27 | 0.140 |
| Vitamin C | 8 | 6 | 0.593 | 8 | 6 | 0.593 |
| DHA | 7 | 8 | 0.796 | 9 | 6 | 0.439 |
| Citicoline | 9 | 8 | 0.808 | 8 | 9 | 0.808 |
| DHA + Citicoline |
16 | 4 | 0.007 | 14 | 6 | 0.074 |
MD, mean defect of visual field; dB, decibels; VFI, visual field index; SD, standard deviation; DHA, docosahexaenoic acid.